Osaic Holdings
CLRB icon

Osaic Holdings’s Cellectar Biosciences CLRB Stock Holding History

Osaic Holdings’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2 Sell
1
-6
-86% -$19 ﹤0.01% 7774
2025
Q4 		$19 Sell
7
-16
-70% -$59 ﹤0.01% 7742
2025
Q3 		$122 Buy
23
+1
+5% +$5 ﹤0.01% 7737
2025
Q2 		$155 Sell
22
-9
-29% -$79 ﹤0.01% 7530
2025
Q1 		$293 Sell
31
-60
-66% -$543 ﹤0.01% 7105
2024
Q4 		$816 Sell
91
-4
-4% -$185 ﹤0.01% 6904
2024
Q3 		$6.09K Hold
95
– – ﹤0.01% 6110
2024
Q2 		$7.12K Buy
95
+78
+459% +$7.49K ﹤0.01% 5999
2024
Q1 		$2.07K Hold
17
– – ﹤0.01% 6454
2023
Q4 		$1.44K Sell
17
-1
-6% -$74 ﹤0.01% 6639
2023
Q3 		$1.43K Buy
18
+1
+6% +$59 ﹤0.01% 6738
2023
Q2 		$1.01K Hold
17
– – ﹤0.01% 6874
2023
Q1 		$745 Hold
17
– – ﹤0.01% 7045
2022
Q4 		$1K Hold
17
– – ﹤0.01% 6848
2022
Q3 		$2K Hold
17
– – ﹤0.01% 6747
2022
Q2 		$2K Sell
17
-1
-6% -$143 ﹤0.01% 6853
2022
Q1 		$3K Hold
18
– – ﹤0.01% 6714
2021
Q4 		$3K Hold
18
– – ﹤0.01% 6856
2021
Q3 		$5K Sell
18
-61
-77% -$18.6K ﹤0.01% 6513
2021
Q2 		$28K Buy
79
+54
+216% +$23.4K ﹤0.01% 5439
2021
Q1 		$12K Buy
25
+4
+19% +$2.38K ﹤0.01% 5766
2020
Q4 		$13K Sell
21
-10
-32% -$4.6K ﹤0.01% 5387
2020
Q3 		$11K Buy
+31
New +$12.2K ﹤0.01% 5209

Other funds holding CLRB

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $349M AUM 33.11% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Osaic Holdings's CLRB Position: Q1 2026 in Review

Osaic Holdings reduced its Cellectar Biosciences (CLRB) stake by 86% in Q1 2026, selling an estimated $19 and leaving 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #7774.

Osaic Holdings first reported a position in CLRB in Q3 2020 and has held it in 23 quarters since. The position peaked at $28K in Q2 2021. 19 funds tracked by Wall St. Rank hold CLRB as of Q1 2026.

  • Osaic Holdings held 1 share of Cellectar Biosciences worth $2 as of Q1 2026.
  • Osaic Holdings sold 6 Cellectar Biosciences shares in Q1 2026, an estimated $19.
  • Cellectar Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7774 holding.
  • Osaic Holdings first reported a position in Cellectar Biosciences in Q3 2020 and has held it in 23 quarters since.
  • Osaic Holdings's Cellectar Biosciences position peaked at $28K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.